Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.53 |
| ▸ | FGFR1 | P11362 | 3/20 | 0.53 |
| ▸ | FGFR2 | P21802 | 3/20 | 0.53 |
| ▸ | FGFR3 | P22607 | 3/20 | 0.53 |
| ▸ | FGFR4 | P22455 | 2/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | METTL3 | Q86U44 | 1/20 | 0.38 |
| ▸ | RET | P07949 | 8/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | ATR | Q13535 | 3/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | USP7 | Q93009 | 1/20 | 0.35 |
| ▸ | NAMPT | P43490 | 1/20 | 0.34 |
| ▸ | PRKDC | P78527 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22675952 | 1.00 | CYP3A4 (0.53) | CYP3A4FGFR1FGFR2FGFR3FGFR4 | |
| SCHEMBL30303767 | 0.95 | CYP3A4 (0.52) | CYP3A4FGFR1FGFR2FGFR3FGFR4 | |
| SCHEMBL22676308 | 0.95 | CYP3A4 (0.52) | CYP3A4FGFR1FGFR2FGFR3FGFR4 | |
| SCHEMBL22675946 | 0.93 | FGFR1 (0.56) | CYP3A4FGFR1FGFR2FGFR3FGFR4 | |
| SCHEMBL30303494 | 0.93 | FGFR1 (0.56) | CYP3A4FGFR1FGFR2FGFR3FGFR4 | |
| SCHEMBL22675953 | 0.92 | CYP3A4 (0.51) | CYP3A4FGFR1FGFR2FGFR3FGFR4 | |
| SCHEMBL22676651 | 0.92 | FGFR1 (0.56) | CYP3A4FGFR1FGFR2FGFR3FGFR4 | |
| SCHEMBL22676224 | 0.91 | FGFR1 (0.55) | CYP3A4FGFR1FGFR2FGFR3FGFR4 | |
| SCHEMBL22676226 | 0.91 | FGFR1 (0.55) | CYP3A4FGFR1FGFR2FGFR3FGFR4 | |
| SCHEMBL30303747 | 0.91 | FGFR1 (0.55) | CYP3A4FGFR1FGFR2FGFR3FGFR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12522605-B2 | FGFR inhibitors and methods of use thereof | RELAY THERAPEUTICS, INC. (US) | 2026-01-13 | — | — | US | disclosed |
| US-11780845-B2 | FGFR inhibitors and methods of use thereof | RELAY THERAPEUTICS, INC. (US) | 2023-10-10 | — | — | US | disclosed |
| US-20230192709-A1 | FGFR INHIBITORS AND METHODS OF USE THEREOF | RELAY THERAPEUTICS, INC. | 2023-06-22 | — | — | US | disclosed |
| US-20230104574-A1 | FGFR INHIBITORS AND METHODS OF USE THEREOF | D.E. SHAW RESEARCH, LLC | 2023-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192709-A1 | FGFR INHIBITORS AND METHODS OF USE THEREOF | FGFR3, FGFR2, FGFR1 | CYP3A4 4283/4885FGFR1 3/4885FGFR2 2/4885 |
| US-20230104574-A1 | FGFR INHIBITORS AND METHODS OF USE THEREOF | FGFR3, FGFR2, FGFR1 | CYP3A4 4283/4885FGFR1 3/4885FGFR2 2/4885 |
| US-11780845-B2 | FGFR inhibitors and methods of use thereof | FGFR3, FGFR2, FGFR1 | CYP3A4 4283/4885FGFR1 3/4885FGFR2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.